Question

I am a breastfeeding mother and i want to know if it is safe to use UK 92480-10? Is UK 92480-10 safe for nursing mother and child? Does UK 92480-10 extracts into breast milk? Does UK 92480-10 has any long term or short term side effects on infants? Can UK 92480-10 influence milk supply or can UK 92480-10 decrease milk supply in lactating mothers?

UK 92480-10 lactation summary

UK 92480-10 is safe in breastfeeding
  • DrLact safety Score for UK 92480-10 is 1 out of 8 which is considered Safe as per our analyses.
  • A safety Score of 1 indicates that usage of UK 92480-10 is mostly safe during lactation for breastfed baby.
  • Our study of different scientific research also indicates that UK 92480-10 does not cause any serious side effects in breastfeeding mothers.
  • Most of scientific studies and research papers declaring usage of UK 92480-10 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
  • Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.

Answer by Dr. Ru: About UK 92480-10 usage in lactation

A 5-phosphodiesterase inhibitor used in the treatment of pulmonary hypertension, erectile dysfunction in men, Raynaud's syndrome and in other treatments due to its vasodilatory effect on smooth muscle. Its use is authorized in small infants and neonates to treat pulmonary hypertension (Lakshminrusimha 2016, Krishnan 2010). UK 92480-10 and its metabolite N-desmethylUK 92480-10 are excreted in breast milk in clinically insignificant amounts, much lower than the dose used in newborns and infants (Wollein 2016).

Answer by DrLact: About UK 92480-10 usage in lactation

Limited data indicate that UK 92480-10 and its active metabolite in breastmilk are poorly excreted into breastmilk. Amounts ingested by the infant are small and would not be expected to cause any adverse effects in breastfed infants.

UK 92480-10 Side Effects in Breastfeeding

A 23-year-old woman with congenital heart disease and pulmonary hypertension was treated during pregnancy with UK 92480-10 and bosentan in unspecified dosages. These drugs and warfarin were continued postpartum. Her infant was delivered at 30 weeks by cesarean section and weighed 1.41 kg at birth. She nursed the infant in the neonatal intensive care unit for 11 weeks "with good outcome" according to the authors, but the infant died at 26 weeks from a respiratory syncytial virus infection.[2]

Alternate Drugs

Disclaimer: Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.